Search

Your search keyword '"Kytölä A"' showing total 785 results

Search Constraints

Start Over You searched for: Author "Kytölä A" Remove constraint Author: "Kytölä A"
785 results on '"Kytölä A"'

Search Results

1. Fock space of local fields of the discrete GFF and its scaling limit bosonic CFT

3. Whole-genome sequencing identifies variants in ANK1, LRRN1, HAS1, and other genes and regulatory regions for stroke in type 1 diabetes

5. TWINGEN: protocol for an observational clinical biobank recall and biomarker cohort study to identify Finnish individuals with high risk of Alzheimer’s disease

6. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank

7. Slit-strip Ising boundary conformal field theory 2: Scaling limits of fusion coefficients

8. High-Resolution Genotyping of Formalin-Fixed Tissue Accurately Estimates Polygenic Risk Scores in Human Diseases

9. The quantum group dual of the first-row subcategory for the generic Virasoro VOA

11. Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial

13. Slit-strip Ising boundary conformal field theory 1: Discrete and continuous function spaces

14. Diagnostic yield of genetic testing in a multinational heterogeneous cohort of 2088 DCM patients

15. The public health impact of poor sleep on severe COVID-19, influenza and upper respiratory infections

16. Longitudinal Metabolome-Wide Signals Prior to the Appearance of a First Islet Autoantibody in Children Participating in the TEDDY Study

18. Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study

20. Whole-exome sequencing identifies novel protein-altering variants associated with serum apolipoprotein and lipid concentrations

21. P409: BCL-2/BCL-XL INHIBITION INDUCES APOPTOSIS AND CIRCUMVENTS VENETOCLAX RESISTANCE IN TP53-MUTATED ACUTE MYELOID LEUKEMIA

22. P562: CAPILLARY BLOOD SAMPLING ALLOWS FEASIBLE METHOD FOR VENETOCLAX CONCENTRATION MEASUREMENT IN AN ACADEMIC MULTICENTER CLINICAL TRIAL CONTEXT

23. Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study

28. Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation

29. Conformal blocks, $q$-combinatorics, and quantum group symmetry

30. Boundary correlations in planar LERW and UST

32. P487: Genetic findings from multi-gene panel for primary ciliary dyskinesia

34. Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia

35. Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women

36. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study

38. Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumors

39. Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)

40. Recontacting biobank participants to collect lifestyle, behavioural and cognitive information via online questionnaires: lessons from a pilot study within FinnGen

41. Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

43. Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)

44. Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts

45. Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

46. Pure partition functions of multiple SLEs

47. Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients

50. Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic Leukemia

Catalog

Books, media, physical & digital resources